Role of the Mmr Efflux Pump in Drug Resistance in Mycobacterium tuberculosis
Open Access
- 1 February 2013
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 57 (2) , 751-757
Abstract
Efflux pumps are membrane proteins capable of actively transporting a broad range of substrates from the cytoplasm to the exterior of the cell. Increased efflux activity in response to drug treatment may be the first step in the development of bacterial drug resistance. Previous studies showed that the efflux pump Mmr was significantly overexpressed in strains exposed to isoniazid. In the work to be described, we constructed mutants lacking or overexpressing Mmr in order to clarify the role of this efflux pump in the development of resistance to isoniazid and other drugs in M. tuberculosis . The mmr knockout mutant showed an increased susceptibility to ethidium bromide, tetraphenylphosphonium, and cetyltrimethylammonium bromide (CTAB). Overexpression of mmr caused a decreased susceptibility to ethidium bromide, acriflavine, and safranin O that was obliterated in the presence of the efflux inhibitors verapamil and carbonyl cyanide m -chlorophenylhydrazone. Isoniazid susceptibility was not affected by the absence or overexpression of mmr . The fluorometric method allowed the detection of a decreased efflux of ethidium bromide in the knockout mutant, whereas the overexpressed strain showed increased efflux of this dye. This increased efflux activity was inhibited in the presence of efflux inhibitors. Under our experimental conditions, we have found that efflux pump Mmr is mainly involved in the susceptibility to quaternary compounds such as ethidium bromide and disinfectants such as CTAB. The contribution of this efflux pump to isoniazid resistance in Mycobacterium tuberculosis still needs to be further elucidated.Keywords
This publication has 30 references indexed in Scilit:
- Efflux Pumps of Mycobacterium tuberculosis Play a Significant Role in Antituberculosis Activity of Potential Drug CandidatesAntimicrobial Agents and Chemotherapy, 2012
- Contribution of Efflux to the Emergence of Isoniazid and Multidrug Resistance in Mycobacterium tuberculosisPLOS ONE, 2012
- Functional and Genetic Characterization of the Tap Efflux Pump in Mycobacterium bovis BCGAntimicrobial Agents and Chemotherapy, 2012
- Identifying co-targets to fight drug resistance based on a random walk modelBMC Systems Biology, 2012
- Multidrug-Resistant Tuberculosis Not Due to Noncompliance but to Between-Patient Pharmacokinetic VariabilityThe Journal of Infectious Diseases, 2011
- Ethidium bromide transport across Mycobacterium smegmatiscell-wall: correlation with antibiotic resistanceBMC Microbiology, 2011
- Fluorometric determination of ethidium bromide efflux kinetics in Escherichia coliJournal of Biological Engineering, 2009
- Role of the Mycobacterium tuberculosis P55 Efflux Pump in Intrinsic Drug Resistance, Oxidative Stress Responses, and GrowthAntimicrobial Agents and Chemotherapy, 2009
- A Balancing Act: Efflux/Influx in Mycobacterial Drug ResistanceAntimicrobial Agents and Chemotherapy, 2009
- Clinically Relevant Chromosomally Encoded Multidrug Resistance Efflux Pumps in BacteriaClinical Microbiology Reviews, 2006